Beginning July 1, 2026, through December 31, 2027, Medicare beneficiaries with Part D coverage may be eligible to access certain GLP-1 medications for $50 per month. To access GLP-1 medications through the demonstration program, an eligible beneficiary must have a medical provider submit a prior authorization request and a prescription for an eligible GLP-1 drug for a covered use. CMS wil
Membership Required
This content is restricted to ACOFP members.
Not a member? Join ACOFP to access this content, plus receive the wealth of benefits and community ACOFP membership offers.
If you need further assistance, please send us a message.